Treatment of postherpetic neuralgia with pregabalin under clinical practice conditions
G Ruf, F Leverkus, R Mallison, M Brasser · Aktuelle Neurologie · 2007 · Heft 09
Bibliografische Angaben
Zusammenfassung
Postherpetic neuralgia (PHN) profoundly affects health-related quality of life and functional status of patients. In addition to pain, often sleep disturbances or anxiety/depression are present (“triad of pain“). While the prevalence of PHN in herpes zoster patients is high (ca. 11%), it is difficult to treat and often refractory to available therapies. Pregabalin, a highly selective ligand for the alpha2-delta subunit protein of voltage-gated calcium channels, reduces release of excitatory neurotransmitters. It is approved for, among other indications, the treatment of peripheral and central neuropathic pain. W…